Published in:
Open Access
01-12-2014 | Research article
An antagonist of the retinoid X receptor reduces the viability of Trichuris muris in vitro
Authors:
Rebecca JM Hurst, Thomas Hopwood, Amanda L Gallagher, Frederick A Partridge, Timothy Burgis, David B Sattelle, Kathryn J Else
Published in:
BMC Infectious Diseases
|
Issue 1/2014
Login to get access
Abstract
Background
Trichuriasis is a parasitic disease caused by the human whipworm, Trichuris trichiura. It affects millions worldwide, particularly in the tropics. This nematode parasite burrows into the colonic epithelium resulting in inflammation and morbidity, especially in children. Current treatment relies mainly on general anthelmintics such as mebendazole but resistance to these drugs is increasingly problematic. Therefore, new treatments are urgently required.
Methods
The prospect of using the retinoid X receptor (RXR) antagonist HX531 as a novel anthelmintic was investigated by carrying out multiple viability assays with the mouse whipworm Trichuris muris.
Results
HX531 reduced both the motility and viability of T. muris at its L3, L4 and adult stages. Further, bioinformatic analyses show that the T. muris genome possesses an RXR-like receptor, a possible target for HX531.
Conclusions
The study suggested that Trichuris-specific RXR antagonists may be a source of much-needed novel anthelmintic candidates for the treatment of trichuriasis. The identification of an RXR-like sequence in the T. muris genome also paves the way for further research based on this new anthelmintic lead compound.